<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03481374</url>
  </required_header>
  <id_info>
    <org_study_id>CVDIABMEL-1</org_study_id>
    <nct_id>NCT03481374</nct_id>
  </id_info>
  <brief_title>Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes Mellitus.</brief_title>
  <official_title>Cardiovascular Autonomic Neuropathy in Patients With Type 1 Diabetes Mellitus.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hasselt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jessa Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hasselt University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      testing of autonomic function and relationship with exercise and Qol in diabetic patients and
      controls
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular autonomic neuropathy is a common (sub)clinical symptom in persons with type 1
      diabetes mellitus. Subjects in this non-commercial, monocentric, interventional study undergo
      autonomic function tests, a maximal ergospirometry and three questionnaires about the quality
      of life (EQ-5D-3L), the capacity to do physical activities (IPAQ) and the experience of
      possible symptoms of autonomic dysfunction in daily life (SCOPA-AUT). In this way the
      influence of type 1 diabetes mellitus on the quality of life, the exercise capacity and the
      autonomic function can be studied.

      The primary aim of this study investigates the potential correlations between the severity of
      diabetic cardiovascular autonomic neuropathy (DCAN) and both the quality of life and the
      exercise capacity. As a secondary aim, the influences of gender, age, number of years since
      diagnosis of type 1 diabetes mellitus, VO2 max predicted, maximal heart rate during exercise,
      minimal heart rate in rest, maximal RER (Respiratory exchange ratio) and relevant interaction
      terms are studied.

      In total 52 test subjects with type 1 diabetes mellitus and 27 matched control subjects are
      selected to participate in this study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2016</start_date>
  <completion_date type="Actual">March 31, 2017</completion_date>
  <primary_completion_date type="Actual">March 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VO2 max</measure>
    <time_frame>day 1</time_frame>
    <description>peak oxygen consumption</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">79</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <arm_group>
    <arm_group_label>subjects with Type 1 Diabetes mellitus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Type 1 diabetes patients without cardiovascular disease undergo autonomic function testing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>healthy people without known disease undergo autonomic function testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>autonomic function testing</intervention_name>
    <description>autonomic function testing, ergospirometry, three questionnaires
Other Names:
The autonomic function tests consist of five tests:
The Valsalva maneuver
The isometric handgrip test
The deep breathing test
The cold pressor test
A short head-up tilt test
A maximal ergospirometry
Three questionnaires:
EQ-5D-3L: quality of life
IPAQ: capacity to do physical activities</description>
    <arm_group_label>subjects with Type 1 Diabetes mellitus</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 diabetes mellitus (only for the group of subjects with diabetes mellitus)

          -  At least two years with diagnosis of type 1 diabetes mellitus

          -  Subject is in a stable condition

          -  No hospitalization for any reason in the past three months

          -  18 years or older

          -  Being capable of doing physical activities

          -  Understand the study design and the informed consent

          -  Sign the informed consent

          -  No simultaneously participation to another study

          -  Being capable of moving to the study center

        Exclusion Criteria:

          -  Uncontrolled hypertension, atrial fibrillation and other cardiovascular conditions

          -  Severe lung disease

          -  Muscle deficiency

          -  Medication with influence on the autonomic nervous system:

               -  Beta blockers

               -  Alfa blockers

               -  Antidepressants

               -  Non-catecholamines

               -  (anti) cholinergic medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Renee De Busser, student</last_name>
    <role>Study Chair</role>
    <affiliation>Hasselt University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anika Nys, student</last_name>
    <role>Study Chair</role>
    <affiliation>Hasselt University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Dendale, prof. dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jessa Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jessa Ziekenhuis</name>
      <address>
        <city>Hasselt</city>
        <zip>3500</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2018</study_first_submitted>
  <study_first_submitted_qc>March 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>April 14, 2018</last_update_submitted>
  <last_update_submitted_qc>April 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hasselt University</investigator_affiliation>
    <investigator_full_name>prof. dr. Paul Dendale</investigator_full_name>
    <investigator_title>prof. dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

